Obesity burden among heart failure patients in an urban safety net hospital: Implications for GLP-1 agonist therapy
The majority of HF patients at an urban safety net hospital are eligible for GLP-1 agonist medications; allocation of these medications to a large patient population represents a major public health challenge.
Authors
- Deepa M. Gopal (ORCID: https://orcid.org/0000-0003-3534-9360)
- Matthew Nayor (ORCID: https://orcid.org/0000-0002-6993-9396)
- Priya Gajjar
- Tracey Yee
Institutions
- Boston University (US)
- University of Vermont (US)
Publication Details
- Journal
- American Heart Journal Plus Cardiology Research and Practice
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.ahjo.2025.100688
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00